SHUKRA PHARMACEUTICALS
Back to Cashflow Statement
|
SHUKRA PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹4.83 Cr | ₹-4.52 Cr | ₹12 Cr | ₹4.94 Cr | ₹-6.68 Cr |
What is the latest Cash Flow from Financing Activities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹4.83 Cr |
| Mar2025 | ₹-4.52 Cr |
| Mar2024 | ₹12 Cr |
| Mar2023 | ₹4.94 Cr |
| Mar2022 | ₹-6.68 Cr |
How is Cash Flow from Financing Activities of SHUKRA PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.83 Cr | Positive | |
| Mar2025 | ₹-4.52 Cr | Negative | |
| Mar2024 | ₹12 Cr | 151.06 | |
| Mar2023 | ₹4.94 Cr | Positive | |
| Mar2022 | ₹-6.68 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹2,964.3 Cr | -4.5% | 23.7% | 94.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | -4.5% |
23.7% |
94.3% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses